GLB1 encodes lysosomal acid beta-galactosidase (beta-Gal), a glycosyl hydrolase family 35 exoglycosidase (EC 3.2.1.23) that catalyzes the hydrolysis of terminal non-reducing beta-D-galactose residues from beta-D-galactosides. Acting within the acidic lysosomal lumen, it degrades the ganglioside GM1 (and its asialo derivative GA1) by removing the terminal galactose, and degrades the glycosaminoglycan keratan sulfate as well as galactose-terminated glycoproteins and oligosaccharides. The mature enzyme is a homodimer/high-molecular-weight multimer that functions in a lysosomal multienzyme complex with protective protein/cathepsin A (CTSA/PPCA), neuraminidase-1 (NEU1), and N-acetylgalactosamine-6-sulfate sulfatase (GALNS); CTSA is required to stabilize the active multimer. It is synthesized as a precursor that is processed through the endoplasmic reticulum and Golgi before reaching the lysosome. Loss of enzyme activity causes the autosomal recessive lysosomal storage diseases GM1-gangliosidosis (types 1, 2, and 3) and mucopolysaccharidosis type IVB (Morquio B syndrome), which are allelic. A catalytically inactive, alternatively spliced isoform (isoform 2; the elastin-binding protein, EBP) instead localizes to the perinuclear cytoplasm/cell surface and participates in elastic-fiber assembly (elastogenesis).
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005764
lysosome
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) annotation placing active beta-galactosidase in the lysosome. This is well supported for GLB1 isoform 1 and represents the core site of action.
Reason: GLB1 is a lysosomal acid hydrolase (pH optimum 4.5-5.5) whose mature enzyme resides and acts in the lysosome; immunoelectron microscopy shows mature high-molecular-weight beta-Gal multimers essentially restricted to the lysosome. is_active_in lysosome is the appropriate core cellular-component/site-of-action term.
Supporting Evidence:
PMID:3084261
In the lysosomes virtually all beta-gal
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0019388
galactose catabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetic (IBA) annotation to galactose catabolic process, reflecting the release of galactose from galactoside substrates.
Reason: By hydrolyzing terminal beta-galactose, GLB1 liberates free galactose, so participation in galactose catabolism is defensible. However, the biologically salient GLB1 catabolic processes are the turnover of gangliosides and glycosaminoglycans/glycoproteins; release of free galactose is a downstream consequence rather than the core physiological role. Retained as non-core.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.
|
|
GO:0004565
beta-galactosidase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) annotation to beta-galactosidase activity, the defining molecular function of GLB1.
Reason: This is the core molecular function. Human beta-Gal hydrolyzes terminal non-reducing beta-D-galactose residues (EC 3.2.1.23), directly demonstrated biochemically and structurally. The IBA is at the correct level of specificity.
Supporting Evidence:
PMID:22128166
exoglycosidase that catalyzes the hydrolysis of terminal
file:human/GLB1/GLB1-uniprot.txt
Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.
|
|
GO:0004553
hydrolase activity, hydrolyzing O-glycosyl compounds
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro-based (IEA) parent term for O-glycosyl hydrolase activity, the general class to which beta-galactosidase activity belongs.
Reason: Correct but less informative than the specific child term GO:0004565 beta-galactosidase activity, which is separately annotated. Retained as a valid, more general parent but not core.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.
|
|
GO:0004565
beta-galactosidase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (IEA) annotation to beta-galactosidase activity via ARBA/InterPro and EC:3.2.1.23.
Reason: Correct core molecular function, consistent with experimental and phylogenetic annotations to the same term.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.
|
|
GO:0005764
lysosome
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (IEA) subcellular-location annotation to lysosome, consistent with UniProt SubCell mapping.
Reason: GLB1 isoform 1 is a lysosomal enzyme; this matches experimental localization evidence.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0005975
carbohydrate metabolic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro-based (IEA) high-level annotation to carbohydrate metabolic process.
Reason: True but very general. The specific catabolic roles (ganglioside catabolism, keratan sulfate proteoglycan catabolism) capture the biology more informatively. Retained as a valid general parent, non-core.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.
|
|
GO:0048471
perinuclear region of cytoplasm
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: UniProt SubCell-mapped (IEA) location to the perinuclear region of cytoplasm.
Reason: This location corresponds specifically to the catalytically inactive isoform 2 (elastin-binding protein/EBP), which UniProt notes is localized to the perinuclear area of the cytoplasm but not to lysosomes. It is not the location of the catalytic lysosomal enzyme and is not a core function of GLB1 the beta-galactosidase; kept as non-core because it is a valid isoform-2 location.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Localized to the perinuclear area of the cytoplasm but not to lysosomes.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding annotations from a systematic binary (Y2H) interactome screen, reporting interactions with the membrane proteins GOLM1, SLC10A6, SLC30A2, and SLC7A1.
Reason: GO:0005515 protein binding is uninformative and does not describe a molecular function of the enzyme. The reported partners (GOLM1 and several SLC transporters) are from a high-throughput binary interactome map and have no established physiological relationship to lysosomal beta-galactosidase; these are most likely non-physiological screen hits. Per curation policy this bare protein-binding IPI is marked as over-annotated rather than removed.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
|
|
GO:0006516
glycoprotein catabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Ortholog-transfer (IEA) annotation to glycoprotein catabolic process.
Reason: GLB1 removes terminal beta-galactose from N-linked and O-linked glycans of glycoproteins; galactose-terminated glycoprotein-derived glycans accumulate when the enzyme is deficient, confirming a role in glycoprotein/glycan catabolism.
Supporting Evidence:
PMID:31720227
N-linked glycan structures that have galactose at their
file:human/GLB1/GLB1-uniprot.txt
Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.
|
|
GO:0006689
ganglioside catabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (IEA) annotation to ganglioside catabolic process, a core biological role of GLB1.
Reason: Beta-Gal removes the terminal galactose of GM1 ganglioside (converting GM1 to GM2) and of its asialo derivative GA1; deficiency causes lysosomal accumulation of GM1 and GA1 (GM1-gangliosidosis). This is a well-established core catabolic function.
Supporting Evidence:
PMID:31720227
leads to the lysosomal accumulation of GM1 and its asialo derivative GA1
|
|
GO:0016936
galactoside binding
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ortholog-transfer (IEA) annotation to galactoside binding.
Reason: Substrate (galactoside) binding is intrinsic to the enzyme's catalytic mechanism (the active site binds the beta-D-galactose moiety), so the annotation is defensible, but it is subsumed by the catalytic beta-galactosidase activity term and is not independently core.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
/ligand="beta-D-galactose"
|
|
GO:0019388
galactose catabolic process
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ortholog-transfer (IEA) duplicate of the galactose catabolic process annotation.
Reason: Same rationale as the IBA annotation to GO:0019388; release of free galactose is a downstream consequence of GLB1 activity rather than its core physiological role.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans.
|
|
GO:0042340
keratan sulfate proteoglycan catabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (IEA) annotation to keratan sulfate proteoglycan catabolic process, a core biological role of GLB1.
Reason: GLB1 removes terminal beta-galactose from keratan sulfate; enzyme deficiency causes keratan sulfate accumulation and Morquio B disease / GM1-gangliosidosis. This is a core catabolic function.
Supporting Evidence:
PMID:22128166
accumulations of the β-Gal substrates, G M1 ganglioside, and keratan sulfate
|
|
GO:0051413
response to cortisone
|
IEA
GO_REF:0000107 |
MARK AS OVER ANNOTATED |
Summary: Electronic annotation to response to cortisone, transferred from a rat ortholog.
Reason: This is an ortholog-transferred (Ensembl Compara) electronic annotation with no human experimental support and no clear connection to the enzyme's molecular function. A transcriptional/physiological response to a steroid is a peripheral phenomenon at best and is likely an over-annotation for the human gene; there is no supporting evidence in the cached literature or UniProt.
Supporting Evidence:
GO_REF:0000107
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
|
|
GO:1904016
response to Thyroglobulin triiodothyronine
|
IEA
GO_REF:0000107 |
MARK AS OVER ANNOTATED |
Summary: Electronic annotation to response to thyroglobulin triiodothyronine, transferred from a rat ortholog.
Reason: Ortholog-transferred electronic annotation with no human experimental support and no relationship to the enzyme's catalytic function. Likely an over-annotation for the human gene.
Supporting Evidence:
GO_REF:0000107
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
|
|
GO:0004565
beta-galactosidase activity
|
TAS
Reactome:R-HSA-2265534 |
ACCEPT |
Summary: Reactome TAS annotation (from the pathway describing defective GLB1 failing to hydrolyze a glycosaminoglycan) supporting beta-galactosidase activity.
Reason: Correct core molecular function, consistent with all other beta-galactosidase activity annotations.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.
|
|
GO:0004565
beta-galactosidase activity
|
TAS
Reactome:R-HSA-9036061 |
ACCEPT |
Summary: Reactome TAS annotation supporting beta-galactosidase activity.
Reason: Correct core molecular function.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.
|
|
GO:0004565
beta-galactosidase activity
|
EXP
PMID:15714521 Role of beta-galactosidase and elastin binding protein in ly... |
ACCEPT |
Summary: Experimental (EXP) annotation to beta-galactosidase activity from expression studies of GLB1 mutations in GM1-gangliosidosis patients, in which GLB1 enzyme activity was measured.
Reason: Direct experimental support for the core beta-galactosidase molecular function; the study measured GLB1 enzyme activity and showed mutations affect it.
Supporting Evidence:
PMID:15714521
the identified mutations affect GLB1 enzyme activity and/or stability
|
|
GO:0004565
beta-galactosidase activity
|
EXP
PMID:19472408 GM1 gangliosidosis and Morquio B disease: expression analysi... |
ACCEPT |
Summary: Experimental (EXP) annotation to beta-galactosidase activity from expression analysis of catalytic-site missense mutations, which measured beta-Gal activity of wild-type and mutant enzymes.
Reason: Direct experimental support for the core molecular function; catalytic-site mutants showed significantly reduced beta-Gal activity relative to normal enzyme.
Supporting Evidence:
PMID:19472408
significantly reduced beta-Gal activities (<10% of normal) upon expression in
|
|
GO:0004565
beta-galactosidase activity
|
EXP
PMID:2511208 Alternative splicing of beta-galactosidase mRNA generates th... |
ACCEPT |
Summary: Experimental (EXP) annotation to beta-galactosidase activity; the classic lysosomal isoform (long cDNA) was shown to be catalytically active in COS-1 cells.
Reason: Direct experimental support that GLB1 isoform 1 encodes an active beta-galactosidase capable of correcting activity in GM1-gangliosidosis fibroblasts.
Supporting Evidence:
PMID:2511208
Only the long protein is catalytically active under the
|
|
GO:0004565
beta-galactosidase activity
|
EXP
PMID:8200356 Hydrolysis of lactosylceramide by human galactosylceramidase... |
ACCEPT |
Summary: Experimental (EXP) annotation to beta-galactosidase activity; GM1-beta-galactosidase (EC 3.2.1.23) was assayed on lactosylceramide and GM1 substrates.
Reason: Direct biochemical support for beta-galactosidase activity on glycosphingolipid substrates (GM1, lactosylceramide), stimulated by saposin activator proteins.
Supporting Evidence:
PMID:8200356
glycosphingolipids: GM1-beta-galactosidase (EC 3.2.1.23) and
|
|
GO:0005764
lysosome
|
EXP
PMID:2511208 Alternative splicing of beta-galactosidase mRNA generates th... |
ACCEPT |
Summary: Experimental (EXP) annotation localizing GLB1 (classic isoform) to the lysosome.
Reason: The classic lysosomal beta-galactosidase isoform localizes to lysosomes; UniProt records the isoform 1 lysosomal location supported by this reference. Core site of action.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0005764
lysosome
|
EXP
PMID:3084261 Immunoelectron microscopical localization of lysosomal beta-... |
ACCEPT |
Summary: Experimental (EXP) immunoelectron-microscopy annotation localizing mature beta-galactosidase to the lysosome.
Reason: Immunoelectron microscopy showed that essentially all mature beta-Gal exists as a high-molecular-weight multimer within the lysosome. Strong experimental support for the core lysosomal location.
Supporting Evidence:
PMID:3084261
In the lysosomes virtually all beta-gal
|
|
GO:0004565
beta-galactosidase activity
|
IDA
PMID:11927518 Endothelial cell senescence in human atherosclerosis: role o... |
MARK AS OVER ANNOTATED |
Summary: IDA annotation to beta-galactosidase activity from a study of endothelial cell senescence in atherosclerosis that used senescence-associated beta-galactosidase (SA-beta-gal) histochemical staining.
Reason: This paper measured senescence-associated beta-galactosidase (SA-beta-gal) activity as a histochemical marker of cell senescence in atherosclerotic tissue, not as a biochemical characterization of the GLB1 enzyme or its substrate specificity. While GLB1 is the enzyme responsible for the SA-beta-gal signal, this is a peripheral phenotypic readout; the core beta-galactosidase activity function is far better supported by the dedicated enzymology and structural papers. Kept but marked over-annotated.
Supporting Evidence:
PMID:11927518
Senescence-associated beta-galactosidase (beta-gal)
|
|
GO:0005975
carbohydrate metabolic process
|
IDA
PMID:11927518 Endothelial cell senescence in human atherosclerosis: role o... |
MARK AS OVER ANNOTATED |
Summary: IDA annotation to carbohydrate metabolic process from the same SA-beta-gal senescence study.
Reason: The supporting paper is about endothelial senescence detected via SA-beta-gal staining and does not characterize carbohydrate metabolism by GLB1. This is both a very general term and derived from a peripheral phenotypic assay; over-annotated.
Supporting Evidence:
PMID:11927518
Senescence-associated beta-galactosidase (beta-gal)
|
|
GO:0004565
beta-galactosidase activity
|
IMP
PMID:8112731 Intracellular processing and maturation of mutant gene produ... |
ACCEPT |
Summary: IMP annotation to beta-galactosidase activity from analysis of mutant enzyme processing and residual catalytic activity in beta-galactosidase deficiency.
Reason: The study assayed catalytic activity of GLB1 mutant enzymes (e.g., low catalytic activity in normally processed Morquio B enzyme), supporting beta-galactosidase activity as the gene's function via loss/alteration of activity in patients.
Supporting Evidence:
PMID:8112731
transported to lysosomes, but its catalytic activity was low
|
|
GO:0005764
lysosome
|
IMP
PMID:8112731 Intracellular processing and maturation of mutant gene produ... |
ACCEPT |
Summary: IMP annotation placing active beta-galactosidase in the lysosome, from study of mutant enzyme trafficking and maturation.
Reason: The study tracked processing/transport of GLB1 to lysosomes and residual lysosomal activity, supporting the lysosome as the site where the enzyme is active. Core location.
Supporting Evidence:
PMID:8112731
transported to lysosomes, but its catalytic activity was low
|
|
GO:0006516
glycoprotein catabolic process
|
IMP
PMID:31720227 Characterization of glycan substrates accumulating in GM1 Ga... |
ACCEPT |
Summary: IMP annotation to glycoprotein catabolic process, from characterization of glycan substrates accumulating in GM1-gangliosidosis (GLB1 deficiency).
Reason: GLB1 deficiency causes accumulation of N-linked and O-linked glycans with terminal beta-linked galactose, demonstrating that GLB1 is required for catabolism of glycoprotein-derived glycans (a "broad oligosaccharidosis"). Core catabolic role.
Supporting Evidence:
PMID:31720227
N-linked glycans with terminal beta-linked
|
|
GO:0006689
ganglioside catabolic process
|
IMP
PMID:31720227 Characterization of glycan substrates accumulating in GM1 Ga... |
ACCEPT |
Summary: IMP annotation to ganglioside catabolic process, from characterization of substrates accumulating in GM1-gangliosidosis.
Reason: GLB1 deficiency leads to lysosomal accumulation of GM1 and its asialo derivative GA1, directly demonstrating GLB1's requirement for ganglioside catabolism. Core function.
Supporting Evidence:
PMID:31720227
leads to the lysosomal accumulation of GM1 and its asialo derivative GA1
|
|
GO:0042340
keratan sulfate proteoglycan catabolic process
|
IMP
PMID:31720227 Characterization of glycan substrates accumulating in GM1 Ga... |
ACCEPT |
Summary: IMP annotation to keratan sulfate proteoglycan catabolic process associated with GLB1 deficiency.
Reason: GLB1 removes terminal beta-galactose from keratan sulfate; its deficiency causes accumulation of keratan sulfate and related galactose-terminated glycans (underlying Morquio B). Core catabolic function.
Supporting Evidence:
PMID:31720227
broad oligosaccharidosis
PMID:22128166
accumulations of the β-Gal substrates, G M1 ganglioside, and keratan sulfate
|
|
GO:0004565
beta-galactosidase activity
|
IDA
PMID:24737316 Structural basis of pharmacological chaperoning for human β-... |
ACCEPT |
Summary: IDA annotation to beta-galactosidase activity from enzymological characterization of purified recombinant human beta-Gal (wild-type and mutants).
Reason: Direct assay of purified recombinant human beta-Gal established its beta-galactosidase enzymology (substrate/inhibitor recognition at the active site). Strong support for the core molecular function.
Supporting Evidence:
PMID:24737316
enzymological properties of purified recombinant human β-Gal
|
|
GO:0005515
protein binding
|
IPI
PMID:22128166 Crystal structure of human β-galactosidase: structural basis... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding annotation from the crystal-structure paper, reflecting the GLB1 homodimer (self-interaction).
Reason: GO:0005515 protein binding is uninformative. The underlying observation (GLB1 self-association) is more precisely captured by the accompanying protein homodimerization activity annotation from the same paper. This bare protein-binding term is redundant and non-informative; marked over-annotated per policy rather than removed.
Supporting Evidence:
PMID:22128166
Human β-Gal is composed of a catalytic TIM barrel domain
|
|
GO:0042803
protein homodimerization activity
|
IPI
PMID:22128166 Crystal structure of human β-galactosidase: structural basis... |
KEEP AS NON CORE |
Summary: IPI annotation to protein homodimerization activity, from the crystal structure showing that human beta-Gal is a homodimer.
Reason: The crystal structure demonstrates that human beta-Gal forms a homodimer, and UniProt records the homodimer subunit structure. This is a real, informative molecular-function annotation, but the enzyme's catalytic activity is its core function; homodimerization is retained as a valid non-core structural property.
Supporting Evidence:
PMID:22128166
crystal structures of human β-Gal
file:human/GLB1/GLB1-uniprot.txt
SUBUNIT: Homodimer
|
|
GO:0005737
cytoplasm
|
IDA
PMID:11927518 Endothelial cell senescence in human atherosclerosis: role o... |
MARK AS OVER ANNOTATED |
Summary: IDA annotation localizing beta-galactosidase signal to the cytoplasm, from the SA-beta-gal senescence/atherosclerosis study.
Reason: The bulk (mature) beta-galactosidase is a lysosomal enzyme; the catalytically inactive isoform 2 is perinuclear-cytoplasmic. A generic cytoplasm localization derived from histochemical SA-beta-gal staining does not reflect the site of action of the catalytic enzyme and conflicts with the strong lysosomal localization evidence. Kept but marked over-annotated.
Supporting Evidence:
PMID:11927518
Senescence-associated beta-galactosidase (beta-gal)
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-6798751 |
KEEP AS NON CORE |
Summary: Reactome TAS annotation to extracellular region via the neutrophil azurophil-granule exocytosis pathway.
Reason: GLB1 can be secreted/released during neutrophil degranulation and is detected extracellularly, but its physiological site of action is the lysosome. Retained as a valid non-core secretory/exocytosis-context location.
Supporting Evidence:
Reactome:R-HSA-6798751
Exocytosis of azurophil granule lumen proteins
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-6800434 |
KEEP AS NON CORE |
Summary: Reactome TAS annotation to extracellular region via the ficolin-rich-granule exocytosis pathway.
Reason: Same rationale as the other extracellular-region annotation; a secretory granule-exocytosis context, not the enzyme's core lysosomal site of action.
Supporting Evidence:
Reactome:R-HSA-6800434
Exocytosis of ficolin-rich granule lumen proteins
|
|
GO:0035578
azurophil granule lumen
|
TAS
Reactome:R-HSA-6798751 |
KEEP AS NON CORE |
Summary: Reactome TAS annotation to azurophil granule lumen (neutrophil degranulation pathway).
Reason: Reflects GLB1's presence in the lumen of neutrophil azurophil granules (a lysosome-related organelle) as part of the neutrophil-degranulation program. A plausible non-core location; not the primary site of the enzyme's catabolic function.
Supporting Evidence:
Reactome:R-HSA-6798751
Exocytosis of azurophil granule lumen proteins
|
|
GO:1904813
ficolin-1-rich granule lumen
|
TAS
Reactome:R-HSA-6800434 |
KEEP AS NON CORE |
Summary: Reactome TAS annotation to ficolin-1-rich granule lumen (neutrophil degranulation pathway).
Reason: Reflects GLB1's presence in the lumen of neutrophil ficolin-1-rich granules as part of the neutrophil-degranulation program. Plausible non-core location.
Supporting Evidence:
Reactome:R-HSA-6800434
Exocytosis of ficolin-rich granule lumen proteins
|
|
GO:0004565
beta-galactosidase activity
|
IMP
PMID:25936995 Recurrent and novel GLB1 mutations in India. |
ACCEPT |
Summary: IMP annotation to beta-galactosidase activity from a large GLB1 mutation study in GM1-gangliosidosis patients, where deficiency of the beta-D-galactosidase enzyme underlies disease.
Reason: The study links GLB1 mutations to deficiency of the beta-D-galactosidase enzyme, and predicts novel mutations affect protein function/structure, supporting the core catalytic function via loss-of-function evidence.
Supporting Evidence:
PMID:25936995
leading to the deficiency of the enzyme
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres... |
KEEP AS NON CORE |
Summary: High-throughput proteomics (HDA) detection of GLB1 in exosomes from prostatic secretions in urine.
Reason: GLB1 is detected in extracellular exosomes by mass spectrometry, consistent with its presence in secretory/extracellular fluids, but this is not its physiological site of action. Valid non-core location from a large-scale proteomics survey.
Supporting Evidence:
PMID:23533145
exosome preparations were characterized by a shotgun proteomics procedure
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:19056867 Large-scale proteomics and phosphoproteomics of urinary exos... |
KEEP AS NON CORE |
Summary: High-throughput proteomics (HDA) detection of GLB1 in urinary exosomes.
Reason: GLB1 was identified in the urinary-exosome proteome by LC-MS/MS. A valid non-core extracellular-vesicle location, not the enzyme's site of action.
Supporting Evidence:
PMID:19056867
profile the proteome of human urinary exosomes
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-2265534 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (defective GLB1 glycosaminoglycan hydrolysis pathway).
Reason: The lysosomal lumen is the precise compartment where the soluble beta-galactosidase acts. This is an accurate, informative core location.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-9036061 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen.
Reason: Accurate core location; the enzyme acts in the lysosomal lumen.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-1605624 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (mobilized GM1 hydrolysis pathway).
Reason: Accurate core location; the enzyme acts in the lysosomal lumen on mobilized GM1.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-1605724 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen.
Reason: Accurate core location; the enzyme acts in the lysosomal lumen.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-1606312 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (GLB1 hydrolyzes SapB/C:LacCer pathway).
Reason: Accurate core location; the enzyme acts in the lysosomal lumen on lactosylceramide presented by saposins.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-1630306 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (GLB1 hydrolyses a glycosaminoglycan pathway).
Reason: Accurate core location; the enzyme acts on glycosaminoglycans in the lysosomal lumen.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-2090079 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (GLB1 hydrolyses keratan sulfate linker chain pathway).
Reason: Accurate core location; the enzyme acts in the lysosomal lumen.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-4084999 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (from a sialic-acid-metabolism pathway that co-locates the CTSA/NEU1/GLB1 complex components).
Reason: Accurate core location; GLB1 resides in the lysosomal lumen alongside the multienzyme complex.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-4341669 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (defective NEU1 pathway that includes GLB1 complex context).
Reason: Accurate core location; the enzyme acts in the lysosomal lumen.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-9638120 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen.
Reason: Accurate core location; the enzyme acts in the lysosomal lumen.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-9840795 |
ACCEPT |
Summary: Reactome TAS annotation to lysosomal lumen (beta-galactosidases hydrolyze GM2A:GA1 to GM2A:GA2 pathway).
Reason: Accurate core location; the enzyme acts in the lysosomal lumen on GA1.
Supporting Evidence:
file:human/GLB1/GLB1-uniprot.txt
SUBCELLULAR LOCATION: [Isoform 1]: Lysosome
|
|
GO:0005515
protein binding
|
IPI
PMID:15498789 Role of a novel EGF-like domain-containing gene NGX6 in cell... |
MARK AS OVER ANNOTATED |
Summary: IPI protein-binding annotation citing the NGX6 nasopharyngeal-carcinoma cell-adhesion paper, with interactant PDGFA (UniProtKB:P15311) recorded in GOA.
Reason: GO:0005515 protein binding is uninformative and does not describe a molecular function of the enzyme. The cited paper concerns NGX6 and cell adhesion in nasopharyngeal carcinoma and does not establish a physiologically meaningful GLB1 interaction. Per policy this bare protein-binding IPI is marked over-annotated rather than removed.
Supporting Evidence:
PMID:15498789
NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells
|
|
GO:0004565
beta-galactosidase activity
|
TAS
PMID:3143362 Cloning, sequencing, and expression of cDNA for human beta-g... |
ACCEPT |
Summary: TAS annotation to beta-galactosidase activity from the original human beta-galactosidase cDNA cloning/expression paper.
Reason: Expression of the cloned human cDNA increased beta-galactosidase activity, establishing that GLB1 encodes an active beta-galactosidase. Core molecular function.
Supporting Evidence:
PMID:3143362
led to an increase in beta-galactosidase activity
|
UniProtKB: P16278 (BGAL_HUMAN). HGNC:4298. EC 3.2.1.23. Glycosyl hydrolase family 35 (CAZy GH35).
GLB1 encodes lysosomal acid beta-galactosidase (β-Gal), an exoglycosidase that
hydrolyses terminal non-reducing β-D-galactose residues from a broad range of
substrates.
Two disease-relevant catabolic roles:
1. Ganglioside/glycosphingolipid catabolism — removes the terminal galactose of GM1
ganglioside (→ GM2) and of its asialo derivative GA1 (→ GA2). Deficiency → lysosomal
accumulation of GM1 and GA1 PMID:31720227. Also acts (with sap-B) on lactosylceramide/GM1 in vitro
PMID:8200356.
2. Keratan sulfate / glycosaminoglycan and glycoprotein catabolism — GM1
gangliosidosis / Morquio B accumulate keratan sulfate and β-galactose-terminated
N-/O-linked glycans. GLB1 deficiency is a "broad oligosaccharidosis" PMID:31720227.
protein binding, uninformative.response to cortisone (GO:0051413) and response to Thyroglobulin triiodothyronineid: P16278
gene_symbol: GLB1
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: GLB1 encodes lysosomal acid beta-galactosidase (beta-Gal), a glycosyl
hydrolase family 35 exoglycosidase (EC 3.2.1.23) that catalyzes the hydrolysis of
terminal non-reducing beta-D-galactose residues from beta-D-galactosides. Acting
within the acidic lysosomal lumen, it degrades the ganglioside GM1 (and its asialo
derivative GA1) by removing the terminal galactose, and degrades the glycosaminoglycan
keratan sulfate as well as galactose-terminated glycoproteins and oligosaccharides.
The mature enzyme is a homodimer/high-molecular-weight multimer that functions in
a lysosomal multienzyme complex with protective protein/cathepsin A (CTSA/PPCA),
neuraminidase-1 (NEU1), and N-acetylgalactosamine-6-sulfate sulfatase (GALNS); CTSA
is required to stabilize the active multimer. It is synthesized as a precursor that
is processed through the endoplasmic reticulum and Golgi before reaching the lysosome.
Loss of enzyme activity causes the autosomal recessive lysosomal storage diseases
GM1-gangliosidosis (types 1, 2, and 3) and mucopolysaccharidosis type IVB (Morquio
B syndrome), which are allelic. A catalytically inactive, alternatively spliced isoform
(isoform 2; the elastin-binding protein, EBP) instead localizes to the perinuclear
cytoplasm/cell surface and participates in elastic-fiber assembly (elastogenesis).
alternative_products:
- name: '1'
id: P16278-1
- name: 2 (Beta-galactosidase-related protein)
id: P16278-2, P16279-1
sequence_note: VSP_031241
- name: '3'
id: P16278-3
sequence_note: VSP_039974
existing_annotations:
- term:
id: GO:0005764
label: lysosome
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: Phylogenetic (IBA) annotation placing active beta-galactosidase in the
lysosome. This is well supported for GLB1 isoform 1 and represents the core
site of action.
action: ACCEPT
reason: GLB1 is a lysosomal acid hydrolase (pH optimum 4.5-5.5) whose mature enzyme
resides and acts in the lysosome; immunoelectron microscopy shows mature high-molecular-weight
beta-Gal multimers essentially restricted to the lysosome. is_active_in lysosome
is the appropriate core cellular-component/site-of-action term.
supported_by:
- reference_id: PMID:3084261
supporting_text: In the lysosomes virtually all beta-gal
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0019388
label: galactose catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetic (IBA) annotation to galactose catabolic process, reflecting
the release of galactose from galactoside substrates.
action: KEEP_AS_NON_CORE
reason: By hydrolyzing terminal beta-galactose, GLB1 liberates free galactose,
so participation in galactose catabolism is defensible. However, the biologically
salient GLB1 catabolic processes are the turnover of gangliosides and glycosaminoglycans/glycoproteins;
release of free galactose is a downstream consequence rather than the core physiological
role. Retained as non-core.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Cleaves beta-linked terminal galactosyl residues from gangliosides,
glycoproteins, and glycosaminoglycans.
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Phylogenetic (IBA) annotation to beta-galactosidase activity, the defining
molecular function of GLB1.
action: ACCEPT
reason: This is the core molecular function. Human beta-Gal hydrolyzes terminal
non-reducing beta-D-galactose residues (EC 3.2.1.23), directly demonstrated
biochemically and structurally. The IBA is at the correct level of specificity.
supported_by:
- reference_id: PMID:22128166
supporting_text: exoglycosidase that catalyzes the hydrolysis of terminal
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Hydrolysis of terminal non-reducing beta-D-galactose residues
in beta-D-galactosides.
- term:
id: GO:0004553
label: hydrolase activity, hydrolyzing O-glycosyl compounds
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: InterPro-based (IEA) parent term for O-glycosyl hydrolase activity, the
general class to which beta-galactosidase activity belongs.
action: KEEP_AS_NON_CORE
reason: Correct but less informative than the specific child term GO:0004565 beta-galactosidase
activity, which is separately annotated. Retained as a valid, more general parent
but not core.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Hydrolysis of terminal non-reducing beta-D-galactose residues
in beta-D-galactosides.
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Automated (IEA) annotation to beta-galactosidase activity via ARBA/InterPro
and EC:3.2.1.23.
action: ACCEPT
reason: Correct core molecular function, consistent with experimental and phylogenetic
annotations to the same term.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Hydrolysis of terminal non-reducing beta-D-galactose residues
in beta-D-galactosides.
- term:
id: GO:0005764
label: lysosome
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: Automated (IEA) subcellular-location annotation to lysosome, consistent
with UniProt SubCell mapping.
action: ACCEPT
reason: GLB1 isoform 1 is a lysosomal enzyme; this matches experimental localization
evidence.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: InterPro-based (IEA) high-level annotation to carbohydrate metabolic
process.
action: KEEP_AS_NON_CORE
reason: True but very general. The specific catabolic roles (ganglioside catabolism,
keratan sulfate proteoglycan catabolism) capture the biology more informatively.
Retained as a valid general parent, non-core.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Cleaves beta-linked terminal galactosyl residues from gangliosides,
glycoproteins, and glycosaminoglycans.
- term:
id: GO:0048471
label: perinuclear region of cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: UniProt SubCell-mapped (IEA) location to the perinuclear region of cytoplasm.
action: KEEP_AS_NON_CORE
reason: This location corresponds specifically to the catalytically inactive isoform
2 (elastin-binding protein/EBP), which UniProt notes is localized to the perinuclear
area of the cytoplasm but not to lysosomes. It is not the location of the catalytic
lysosomal enzyme and is not a core function of GLB1 the beta-galactosidase; kept
as non-core because it is a valid isoform-2 location.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Localized to the perinuclear area of the cytoplasm but not to
lysosomes.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: IPI protein-binding annotations from a systematic binary (Y2H) interactome
screen, reporting interactions with the membrane proteins GOLM1, SLC10A6, SLC30A2,
and SLC7A1.
action: MARK_AS_OVER_ANNOTATED
reason: 'GO:0005515 protein binding is uninformative and does not describe a molecular
function of the enzyme. The reported partners (GOLM1 and several SLC transporters)
are from a high-throughput binary interactome map and have no established physiological
relationship to lysosomal beta-galactosidase; these are most likely non-physiological
screen hits. Per curation policy this bare protein-binding IPI is marked as over-annotated
rather than removed.'
supported_by:
- reference_id: PMID:32296183
supporting_text: A reference map of the human binary protein interactome.
- term:
id: GO:0006516
label: glycoprotein catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Ortholog-transfer (IEA) annotation to glycoprotein catabolic process.
action: ACCEPT
reason: GLB1 removes terminal beta-galactose from N-linked and O-linked glycans
of glycoproteins; galactose-terminated glycoprotein-derived glycans accumulate
when the enzyme is deficient, confirming a role in glycoprotein/glycan catabolism.
supported_by:
- reference_id: PMID:31720227
supporting_text: N-linked glycan structures that have galactose at their
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Cleaves beta-linked terminal galactosyl residues from gangliosides,
glycoproteins, and glycosaminoglycans.
- term:
id: GO:0006689
label: ganglioside catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Automated (IEA) annotation to ganglioside catabolic process, a core biological
role of GLB1.
action: ACCEPT
reason: Beta-Gal removes the terminal galactose of GM1 ganglioside (converting
GM1 to GM2) and of its asialo derivative GA1; deficiency causes lysosomal accumulation
of GM1 and GA1 (GM1-gangliosidosis). This is a well-established core catabolic
function.
supported_by:
- reference_id: PMID:31720227
supporting_text: leads to the lysosomal accumulation of GM1 and its asialo derivative
GA1
- term:
id: GO:0016936
label: galactoside binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: Ortholog-transfer (IEA) annotation to galactoside binding.
action: KEEP_AS_NON_CORE
reason: Substrate (galactoside) binding is intrinsic to the enzyme's catalytic
mechanism (the active site binds the beta-D-galactose moiety), so the annotation
is defensible, but it is subsumed by the catalytic beta-galactosidase activity
term and is not independently core.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: /ligand="beta-D-galactose"
- term:
id: GO:0019388
label: galactose catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Ortholog-transfer (IEA) duplicate of the galactose catabolic process
annotation.
action: KEEP_AS_NON_CORE
reason: Same rationale as the IBA annotation to GO:0019388; release of free galactose
is a downstream consequence of GLB1 activity rather than its core physiological
role.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Cleaves beta-linked terminal galactosyl residues from gangliosides,
glycoproteins, and glycosaminoglycans.
- term:
id: GO:0042340
label: keratan sulfate proteoglycan catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Automated (IEA) annotation to keratan sulfate proteoglycan catabolic
process, a core biological role of GLB1.
action: ACCEPT
reason: GLB1 removes terminal beta-galactose from keratan sulfate; enzyme deficiency
causes keratan sulfate accumulation and Morquio B disease / GM1-gangliosidosis.
This is a core catabolic function.
supported_by:
- reference_id: PMID:22128166
supporting_text: accumulations of the β-Gal substrates, G M1 ganglioside, and
keratan sulfate
- term:
id: GO:0051413
label: response to cortisone
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Electronic annotation to response to cortisone, transferred from a rat
ortholog.
action: MARK_AS_OVER_ANNOTATED
reason: This is an ortholog-transferred (Ensembl Compara) electronic annotation
with no human experimental support and no clear connection to the enzyme's molecular
function. A transcriptional/physiological response to a steroid is a peripheral
phenomenon at best and is likely an over-annotation for the human gene; there
is no supporting evidence in the cached literature or UniProt.
supported_by:
- reference_id: GO_REF:0000107
supporting_text: Automatic transfer of experimentally verified manual GO annotation
data to orthologs using Ensembl Compara
- term:
id: GO:1904016
label: response to Thyroglobulin triiodothyronine
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Electronic annotation to response to thyroglobulin triiodothyronine,
transferred from a rat ortholog.
action: MARK_AS_OVER_ANNOTATED
reason: Ortholog-transferred electronic annotation with no human experimental
support and no relationship to the enzyme's catalytic function. Likely an over-annotation
for the human gene.
supported_by:
- reference_id: GO_REF:0000107
supporting_text: Automatic transfer of experimentally verified manual GO annotation
data to orthologs using Ensembl Compara
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2265534
qualifier: enables
review:
summary: Reactome TAS annotation (from the pathway describing defective GLB1 failing
to hydrolyze a glycosaminoglycan) supporting beta-galactosidase activity.
action: ACCEPT
reason: Correct core molecular function, consistent with all other beta-galactosidase
activity annotations.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Hydrolysis of terminal non-reducing beta-D-galactose residues
in beta-D-galactosides.
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9036061
qualifier: enables
review:
summary: Reactome TAS annotation supporting beta-galactosidase activity.
action: ACCEPT
reason: Correct core molecular function.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Hydrolysis of terminal non-reducing beta-D-galactose residues
in beta-D-galactosides.
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: EXP
original_reference_id: PMID:15714521
qualifier: enables
review:
summary: Experimental (EXP) annotation to beta-galactosidase activity from expression
studies of GLB1 mutations in GM1-gangliosidosis patients, in which GLB1 enzyme
activity was measured.
action: ACCEPT
reason: Direct experimental support for the core beta-galactosidase molecular
function; the study measured GLB1 enzyme activity and showed mutations affect
it.
supported_by:
- reference_id: PMID:15714521
supporting_text: the identified mutations affect GLB1 enzyme activity and/or
stability
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: EXP
original_reference_id: PMID:19472408
qualifier: enables
review:
summary: Experimental (EXP) annotation to beta-galactosidase activity from expression
analysis of catalytic-site missense mutations, which measured beta-Gal activity
of wild-type and mutant enzymes.
action: ACCEPT
reason: Direct experimental support for the core molecular function; catalytic-site
mutants showed significantly reduced beta-Gal activity relative to normal enzyme.
supported_by:
- reference_id: PMID:19472408
supporting_text: significantly reduced beta-Gal activities (<10% of normal) upon
expression in
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: EXP
original_reference_id: PMID:2511208
qualifier: enables
review:
summary: Experimental (EXP) annotation to beta-galactosidase activity; the classic
lysosomal isoform (long cDNA) was shown to be catalytically active in COS-1
cells.
action: ACCEPT
reason: Direct experimental support that GLB1 isoform 1 encodes an active beta-galactosidase
capable of correcting activity in GM1-gangliosidosis fibroblasts.
supported_by:
- reference_id: PMID:2511208
supporting_text: Only the long protein is catalytically active under the
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: EXP
original_reference_id: PMID:8200356
qualifier: enables
review:
summary: Experimental (EXP) annotation to beta-galactosidase activity; GM1-beta-galactosidase
(EC 3.2.1.23) was assayed on lactosylceramide and GM1 substrates.
action: ACCEPT
reason: Direct biochemical support for beta-galactosidase activity on glycosphingolipid
substrates (GM1, lactosylceramide), stimulated by saposin activator proteins.
supported_by:
- reference_id: PMID:8200356
supporting_text: 'glycosphingolipids: GM1-beta-galactosidase (EC 3.2.1.23) and'
- term:
id: GO:0005764
label: lysosome
evidence_type: EXP
original_reference_id: PMID:2511208
qualifier: located_in
review:
summary: Experimental (EXP) annotation localizing GLB1 (classic isoform) to the
lysosome.
action: ACCEPT
reason: The classic lysosomal beta-galactosidase isoform localizes to lysosomes;
UniProt records the isoform 1 lysosomal location supported by this reference.
Core site of action.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0005764
label: lysosome
evidence_type: EXP
original_reference_id: PMID:3084261
qualifier: located_in
review:
summary: Experimental (EXP) immunoelectron-microscopy annotation localizing mature
beta-galactosidase to the lysosome.
action: ACCEPT
reason: Immunoelectron microscopy showed that essentially all mature beta-Gal
exists as a high-molecular-weight multimer within the lysosome. Strong experimental
support for the core lysosomal location.
supported_by:
- reference_id: PMID:3084261
supporting_text: In the lysosomes virtually all beta-gal
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: IDA
original_reference_id: PMID:11927518
qualifier: enables
review:
summary: IDA annotation to beta-galactosidase activity from a study of endothelial
cell senescence in atherosclerosis that used senescence-associated beta-galactosidase
(SA-beta-gal) histochemical staining.
action: MARK_AS_OVER_ANNOTATED
reason: This paper measured senescence-associated beta-galactosidase (SA-beta-gal)
activity as a histochemical marker of cell senescence in atherosclerotic tissue,
not as a biochemical characterization of the GLB1 enzyme or its substrate specificity.
While GLB1 is the enzyme responsible for the SA-beta-gal signal, this is a peripheral
phenotypic readout; the core beta-galactosidase activity function is far better
supported by the dedicated enzymology and structural papers. Kept but marked
over-annotated.
supported_by:
- reference_id: PMID:11927518
supporting_text: Senescence-associated beta-galactosidase (beta-gal)
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: IDA
original_reference_id: PMID:11927518
qualifier: involved_in
review:
summary: IDA annotation to carbohydrate metabolic process from the same SA-beta-gal
senescence study.
action: MARK_AS_OVER_ANNOTATED
reason: The supporting paper is about endothelial senescence detected via SA-beta-gal
staining and does not characterize carbohydrate metabolism by GLB1. This is
both a very general term and derived from a peripheral phenotypic assay; over-annotated.
supported_by:
- reference_id: PMID:11927518
supporting_text: Senescence-associated beta-galactosidase (beta-gal)
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: IMP
original_reference_id: PMID:8112731
qualifier: enables
review:
summary: IMP annotation to beta-galactosidase activity from analysis of mutant
enzyme processing and residual catalytic activity in beta-galactosidase deficiency.
action: ACCEPT
reason: The study assayed catalytic activity of GLB1 mutant enzymes (e.g., low
catalytic activity in normally processed Morquio B enzyme), supporting beta-galactosidase
activity as the gene's function via loss/alteration of activity in patients.
supported_by:
- reference_id: PMID:8112731
supporting_text: transported to lysosomes, but its catalytic activity was low
- term:
id: GO:0005764
label: lysosome
evidence_type: IMP
original_reference_id: PMID:8112731
qualifier: is_active_in
review:
summary: IMP annotation placing active beta-galactosidase in the lysosome, from
study of mutant enzyme trafficking and maturation.
action: ACCEPT
reason: The study tracked processing/transport of GLB1 to lysosomes and residual
lysosomal activity, supporting the lysosome as the site where the enzyme is
active. Core location.
supported_by:
- reference_id: PMID:8112731
supporting_text: transported to lysosomes, but its catalytic activity was low
- term:
id: GO:0006516
label: glycoprotein catabolic process
evidence_type: IMP
original_reference_id: PMID:31720227
qualifier: involved_in
review:
summary: IMP annotation to glycoprotein catabolic process, from characterization
of glycan substrates accumulating in GM1-gangliosidosis (GLB1 deficiency).
action: ACCEPT
reason: GLB1 deficiency causes accumulation of N-linked and O-linked glycans with
terminal beta-linked galactose, demonstrating that GLB1 is required for catabolism
of glycoprotein-derived glycans (a "broad oligosaccharidosis"). Core catabolic
role.
supported_by:
- reference_id: PMID:31720227
supporting_text: N-linked glycans with terminal beta-linked
- term:
id: GO:0006689
label: ganglioside catabolic process
evidence_type: IMP
original_reference_id: PMID:31720227
qualifier: involved_in
review:
summary: IMP annotation to ganglioside catabolic process, from characterization
of substrates accumulating in GM1-gangliosidosis.
action: ACCEPT
reason: GLB1 deficiency leads to lysosomal accumulation of GM1 and its asialo
derivative GA1, directly demonstrating GLB1's requirement for ganglioside catabolism.
Core function.
supported_by:
- reference_id: PMID:31720227
supporting_text: leads to the lysosomal accumulation of GM1 and its asialo derivative
GA1
- term:
id: GO:0042340
label: keratan sulfate proteoglycan catabolic process
evidence_type: IMP
original_reference_id: PMID:31720227
qualifier: involved_in
review:
summary: IMP annotation to keratan sulfate proteoglycan catabolic process associated
with GLB1 deficiency.
action: ACCEPT
reason: GLB1 removes terminal beta-galactose from keratan sulfate; its deficiency
causes accumulation of keratan sulfate and related galactose-terminated glycans
(underlying Morquio B). Core catabolic function.
supported_by:
- reference_id: PMID:31720227
supporting_text: broad oligosaccharidosis
- reference_id: PMID:22128166
supporting_text: accumulations of the β-Gal substrates, G M1 ganglioside, and
keratan sulfate
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: IDA
original_reference_id: PMID:24737316
qualifier: enables
review:
summary: IDA annotation to beta-galactosidase activity from enzymological characterization
of purified recombinant human beta-Gal (wild-type and mutants).
action: ACCEPT
reason: Direct assay of purified recombinant human beta-Gal established its beta-galactosidase
enzymology (substrate/inhibitor recognition at the active site). Strong support
for the core molecular function.
supported_by:
- reference_id: PMID:24737316
supporting_text: enzymological properties of purified recombinant human β-Gal
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:22128166
qualifier: enables
review:
summary: IPI protein-binding annotation from the crystal-structure paper, reflecting
the GLB1 homodimer (self-interaction).
action: MARK_AS_OVER_ANNOTATED
reason: GO:0005515 protein binding is uninformative. The underlying observation
(GLB1 self-association) is more precisely captured by the accompanying protein
homodimerization activity annotation from the same paper. This bare protein-binding
term is redundant and non-informative; marked over-annotated per policy rather
than removed.
supported_by:
- reference_id: PMID:22128166
supporting_text: Human β-Gal is composed of a catalytic TIM barrel domain
- term:
id: GO:0042803
label: protein homodimerization activity
evidence_type: IPI
original_reference_id: PMID:22128166
qualifier: enables
review:
summary: IPI annotation to protein homodimerization activity, from the crystal
structure showing that human beta-Gal is a homodimer.
action: KEEP_AS_NON_CORE
reason: The crystal structure demonstrates that human beta-Gal forms a homodimer,
and UniProt records the homodimer subunit structure. This is a real, informative
molecular-function annotation, but the enzyme's catalytic activity is its core
function; homodimerization is retained as a valid non-core structural property.
supported_by:
- reference_id: PMID:22128166
supporting_text: crystal structures of human β-Gal
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBUNIT: Homodimer'
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:11927518
qualifier: located_in
review:
summary: IDA annotation localizing beta-galactosidase signal to the cytoplasm,
from the SA-beta-gal senescence/atherosclerosis study.
action: MARK_AS_OVER_ANNOTATED
reason: The bulk (mature) beta-galactosidase is a lysosomal enzyme; the catalytically
inactive isoform 2 is perinuclear-cytoplasmic. A generic cytoplasm localization
derived from histochemical SA-beta-gal staining does not reflect the site of
action of the catalytic enzyme and conflicts with the strong lysosomal localization
evidence. Kept but marked over-annotated.
supported_by:
- reference_id: PMID:11927518
supporting_text: Senescence-associated beta-galactosidase (beta-gal)
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798751
qualifier: located_in
review:
summary: Reactome TAS annotation to extracellular region via the neutrophil azurophil-granule
exocytosis pathway.
action: KEEP_AS_NON_CORE
reason: GLB1 can be secreted/released during neutrophil degranulation and is detected
extracellularly, but its physiological site of action is the lysosome. Retained
as a valid non-core secretory/exocytosis-context location.
supported_by:
- reference_id: Reactome:R-HSA-6798751
supporting_text: Exocytosis of azurophil granule lumen proteins
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6800434
qualifier: located_in
review:
summary: Reactome TAS annotation to extracellular region via the ficolin-rich-granule
exocytosis pathway.
action: KEEP_AS_NON_CORE
reason: Same rationale as the other extracellular-region annotation; a secretory
granule-exocytosis context, not the enzyme's core lysosomal site of action.
supported_by:
- reference_id: Reactome:R-HSA-6800434
supporting_text: Exocytosis of ficolin-rich granule lumen proteins
- term:
id: GO:0035578
label: azurophil granule lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798751
qualifier: located_in
review:
summary: Reactome TAS annotation to azurophil granule lumen (neutrophil degranulation
pathway).
action: KEEP_AS_NON_CORE
reason: Reflects GLB1's presence in the lumen of neutrophil azurophil granules
(a lysosome-related organelle) as part of the neutrophil-degranulation program.
A plausible non-core location; not the primary site of the enzyme's catabolic
function.
supported_by:
- reference_id: Reactome:R-HSA-6798751
supporting_text: Exocytosis of azurophil granule lumen proteins
- term:
id: GO:1904813
label: ficolin-1-rich granule lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6800434
qualifier: located_in
review:
summary: Reactome TAS annotation to ficolin-1-rich granule lumen (neutrophil degranulation
pathway).
action: KEEP_AS_NON_CORE
reason: Reflects GLB1's presence in the lumen of neutrophil ficolin-1-rich granules
as part of the neutrophil-degranulation program. Plausible non-core location.
supported_by:
- reference_id: Reactome:R-HSA-6800434
supporting_text: Exocytosis of ficolin-rich granule lumen proteins
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: IMP
original_reference_id: PMID:25936995
qualifier: enables
review:
summary: IMP annotation to beta-galactosidase activity from a large GLB1 mutation
study in GM1-gangliosidosis patients, where deficiency of the beta-D-galactosidase
enzyme underlies disease.
action: ACCEPT
reason: The study links GLB1 mutations to deficiency of the beta-D-galactosidase
enzyme, and predicts novel mutations affect protein function/structure, supporting
the core catalytic function via loss-of-function evidence.
supported_by:
- reference_id: PMID:25936995
supporting_text: leading to the deficiency of the enzyme
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:23533145
qualifier: located_in
review:
summary: High-throughput proteomics (HDA) detection of GLB1 in exosomes from prostatic
secretions in urine.
action: KEEP_AS_NON_CORE
reason: GLB1 is detected in extracellular exosomes by mass spectrometry, consistent
with its presence in secretory/extracellular fluids, but this is not its physiological
site of action. Valid non-core location from a large-scale proteomics survey.
supported_by:
- reference_id: PMID:23533145
supporting_text: exosome preparations were characterized by a shotgun proteomics
procedure
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:19056867
qualifier: located_in
review:
summary: High-throughput proteomics (HDA) detection of GLB1 in urinary exosomes.
action: KEEP_AS_NON_CORE
reason: GLB1 was identified in the urinary-exosome proteome by LC-MS/MS. A valid
non-core extracellular-vesicle location, not the enzyme's site of action.
supported_by:
- reference_id: PMID:19056867
supporting_text: profile the proteome of human urinary exosomes
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2265534
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (defective GLB1 glycosaminoglycan
hydrolysis pathway).
action: ACCEPT
reason: The lysosomal lumen is the precise compartment where the soluble beta-galactosidase
acts. This is an accurate, informative core location.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9036061
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen.
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1605624
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (mobilized GM1 hydrolysis pathway).
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen on mobilized
GM1.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1605724
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen.
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1606312
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (GLB1 hydrolyzes SapB/C:LacCer
pathway).
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen on lactosylceramide
presented by saposins.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1630306
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (GLB1 hydrolyses a glycosaminoglycan
pathway).
action: ACCEPT
reason: Accurate core location; the enzyme acts on glycosaminoglycans in the lysosomal
lumen.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2090079
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (GLB1 hydrolyses keratan sulfate
linker chain pathway).
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4084999
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (from a sialic-acid-metabolism
pathway that co-locates the CTSA/NEU1/GLB1 complex components).
action: ACCEPT
reason: Accurate core location; GLB1 resides in the lysosomal lumen alongside
the multienzyme complex.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4341669
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (defective NEU1 pathway that
includes GLB1 complex context).
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9638120
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen.
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9840795
qualifier: located_in
review:
summary: Reactome TAS annotation to lysosomal lumen (beta-galactosidases hydrolyze
GM2A:GA1 to GM2A:GA2 pathway).
action: ACCEPT
reason: Accurate core location; the enzyme acts in the lysosomal lumen on GA1.
supported_by:
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: [Isoform 1]: Lysosome'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15498789
qualifier: enables
review:
summary: IPI protein-binding annotation citing the NGX6 nasopharyngeal-carcinoma
cell-adhesion paper, with interactant PDGFA (UniProtKB:P15311) recorded in GOA.
action: MARK_AS_OVER_ANNOTATED
reason: GO:0005515 protein binding is uninformative and does not describe a molecular
function of the enzyme. The cited paper concerns NGX6 and cell adhesion in nasopharyngeal
carcinoma and does not establish a physiologically meaningful GLB1 interaction.
Per policy this bare protein-binding IPI is marked over-annotated rather than
removed.
supported_by:
- reference_id: PMID:15498789
supporting_text: NGX6 in cell adhesion modulation in nasopharyngeal carcinoma
cells
- term:
id: GO:0004565
label: beta-galactosidase activity
evidence_type: TAS
original_reference_id: PMID:3143362
qualifier: enables
review:
summary: TAS annotation to beta-galactosidase activity from the original human
beta-galactosidase cDNA cloning/expression paper.
action: ACCEPT
reason: Expression of the cloned human cDNA increased beta-galactosidase activity,
establishing that GLB1 encodes an active beta-galactosidase. Core molecular
function.
supported_by:
- reference_id: PMID:3143362
supporting_text: led to an increase in beta-galactosidase activity
core_functions:
- description: Lysosomal acid beta-galactosidase that hydrolyzes terminal non-reducing
beta-D-galactose residues from beta-D-galactosides, acting in the lysosomal lumen
as part of a multienzyme complex with CTSA/PPCA and NEU1.
molecular_function:
id: GO:0004565
label: beta-galactosidase activity
directly_involved_in:
- id: GO:0006689
label: ganglioside catabolic process
locations:
- id: GO:0043202
label: lysosomal lumen
supported_by:
- reference_id: PMID:31720227
supporting_text: leads to the lysosomal accumulation of GM1 and its asialo derivative
GA1
- reference_id: PMID:22128166
supporting_text: exoglycosidase that catalyzes the hydrolysis of terminal
- description: Lysosomal acid beta-galactosidase that degrades the glycosaminoglycan
keratan sulfate (and galactose-terminated glycoprotein/oligosaccharide glycans)
by removing terminal beta-galactose residues in the lysosome.
molecular_function:
id: GO:0004565
label: beta-galactosidase activity
directly_involved_in:
- id: GO:0042340
label: keratan sulfate proteoglycan catabolic process
locations:
- id: GO:0005764
label: lysosome
supported_by:
- reference_id: PMID:22128166
supporting_text: accumulations of the β-Gal substrates, G M1 ganglioside, and
keratan sulfate
- reference_id: file:human/GLB1/GLB1-uniprot.txt
supporting_text: Cleaves beta-linked terminal galactosyl residues from gangliosides,
glycoproteins, and glycosaminoglycans.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: file:human/GLB1/GLB1-uniprot.txt
title: UniProtKB entry P16278 (BGAL_HUMAN), Beta-galactosidase
findings: []
- id: PMID:11927518
title: 'Endothelial cell senescence in human atherosclerosis: role of telomere in
endothelial dysfunction.'
findings: []
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: Measures senescence-associated beta-galactosidase (SA-beta-gal)
histochemical staining as a senescence marker; does not biochemically characterize
GLB1 substrate specificity or localization. The IDA beta-galactosidase-activity,
carbohydrate-metabolic-process, and cytoplasm annotations derived from it are
over-annotations.
- id: PMID:15498789
title: Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation
in nasopharyngeal carcinoma cells.
findings: []
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: Paper concerns NGX6 and cell adhesion in nasopharyngeal carcinoma;
does not establish a physiologically meaningful GLB1 protein interaction. Supports
only a bare, uninformative protein-binding annotation.
- id: PMID:15714521
title: Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal
complexes of patients with GM1-gangliosidosis.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Establishes the lysosomal multienzyme complex of GLB1 with PPCA/CTSA,
NEU1, and GALNS, and shows disease mutations affect GLB1 activity/stability.
- id: PMID:19056867
title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Large-scale proteomics detecting GLB1 in urinary exosomes; supports
a non-core extracellular-exosome location only.
- id: PMID:19472408
title: 'GM1 gangliosidosis and Morquio B disease: expression analysis of missense
mutations affecting the catalytic site of acid beta-galactosidase.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Expression analysis of catalytic-site missense mutants directly
measured beta-Gal activity; supports the core molecular function.
- id: PMID:22128166
title: 'Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis
and morquio B diseases.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Crystal structure defining beta-Gal as an exoglycosidase hydrolyzing
terminal beta-linked galactose, the homodimer, TIM-barrel active site, and the
GM1/keratan sulfate substrates.
- id: PMID:23533145
title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
secretions in urine.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Shotgun proteomics detecting GLB1 in prostatic-secretion exosomes;
supports a non-core extracellular-exosome location only.
- id: PMID:24737316
title: Structural basis of pharmacological chaperoning for human β-galactosidase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Enzymological characterization of purified recombinant human beta-Gal
(WT and mutants) and active-site ligand recognition; supports the core catalytic
function.
- id: PMID:2511208
title: Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal
enzyme and a beta-galactosidase-related protein.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Shows the classic long isoform is the catalytically active lysosomal
enzyme, distinct from the inactive beta-galactosidase-related protein (isoform
2 / EBP).
- id: PMID:25936995
title: Recurrent and novel GLB1 mutations in India.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Large GLB1 mutation series in GM1-gangliosidosis; links mutations
to beta-D-galactosidase deficiency and predicts functional/structural impact.
- id: PMID:3084261
title: Immunoelectron microscopical localization of lysosomal beta-galactosidase
and its precursor forms in normal and mutant human fibroblasts.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Immunoelectron microscopy localizing mature high-MW beta-Gal multimers
to the lysosome, with precursor forms in RER/Golgi; PPCA restores multimers.
- id: PMID:3143362
title: Cloning, sequencing, and expression of cDNA for human beta-galactosidase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Original cloning/expression of human beta-galactosidase cDNA; expression
increased beta-galactosidase activity.
- id: PMID:31720227
title: Characterization of glycan substrates accumulating in GM1 Gangliosidosis.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Defines GLB1 as a lysosomal hydrolase removing beta-galactose from
the non-reducing end of glycans; deficiency causes accumulation of GM1, GA1,
and N-/O-linked galactose-terminated glycans (broad oligosaccharidosis).
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: MISCITED
review_notes: High-throughput binary (Y2H) interactome map; the reported GLB1
partners (GOLM1, SLC10A6, SLC30A2, SLC7A1) are likely non-physiological screen
hits and support only a bare protein-binding annotation.
- id: PMID:8112731
title: Intracellular processing and maturation of mutant gene products in hereditary
beta-galactosidase deficiency (beta-galactosidosis).
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Analyzes processing/trafficking and residual catalytic activity
of GLB1 mutant enzymes across GM1-gangliosidosis and Morquio B forms.
- id: PMID:8200356
title: Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase
in a detergent-free system and its stimulation by sphingolipid activator proteins,
sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Biochemical assay of GM1-beta-galactosidase (EC 3.2.1.23) on GM1
and lactosylceramide, stimulated by saposin activator proteins.
- id: Reactome:R-HSA-1605624
title: Beta-galactosidases hydrolyse mobilized GM1 to mobilized GM2
findings: []
- id: Reactome:R-HSA-1605724
title: NEU1,4 hydrolyze PSAP(195-273):GM3:PE
findings: []
- id: Reactome:R-HSA-1606312
title: GLB1 hydrolyzes SapB/C:LacCer
findings: []
- id: Reactome:R-HSA-1630306
title: GLB1 hydrolyses a glycosaminoglycan
findings: []
- id: Reactome:R-HSA-2090079
title: GLB1 hydrolyses linker chain(2)
findings: []
- id: Reactome:R-HSA-2265534
title: Defective GLB1 does not hydrolyse a glycosaminoglycan
findings: []
- id: Reactome:R-HSA-4084999
title: NEU1 hydrolyses Neu5Ac from glycoconjugates
findings: []
- id: Reactome:R-HSA-4341669
title: Defective NEU1 does not hydrolyse Neu5Ac from glycoconjugates
findings: []
- id: Reactome:R-HSA-6798751
title: Exocytosis of azurophil granule lumen proteins
findings: []
- id: Reactome:R-HSA-6800434
title: Exocytosis of ficolin-rich granule lumen proteins
findings: []
- id: Reactome:R-HSA-9036061
title: Defective GLB1 does not hydrolyse linker chain(2)
findings: []
- id: Reactome:R-HSA-9638120
title: NEU4 hydrolyses Neu5Ac from glycoconjugates
findings: []
- id: Reactome:R-HSA-9840795
title: Beta-galactosidases hydrolyze GM2A:GA1 to GM2A:GA2
findings: []